| Financial Year |
March 31 2023 |
| Monetary Funds |
1,654,711,281.85 |
| Held-for-trading Financial Assets |
120,000,000.00 |
| Notes Receivable |
47,089,588.84 |
| Accounts Receivable |
1,300,843,973.62 |
| Advances to Suppliers |
125,438,933.72 |
| Other Receivables |
25,536,079.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
594,264,385.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,011,819.16 |
| Total Current Assets |
3,941,486,492.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
38,622,507.63 |
| Investment Properties |
35,440,788.64 |
| Fixed Assetes |
768,561,149.92 |
| Under-construction Projects |
32,829,386.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
65,863,248.33 |
| R&D expenses |
-- |
| Goodwill |
263,040,430.36 |
| Long-Term Deferred and Prepaid Expenses |
1,636,099.96 |
| Deferred Income Tax Assets |
28,528,442.98 |
| Other Non-Current Assets |
21,544,355.52 |
| Sub-Total of Non-Current Assets |
1,299,397,555.70 |
| Total Assets |
5,240,884,047.73 |
| Short-Term Loans |
771,833,667.71 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,293,648,517.19 |
| Accounts Payable |
98,185,821.34 |
| Accounts Received In Advance |
330,574.72 |
| Employee Compensation Payable |
7,815,661.58 |
| Taxes Payable |
10,253,355.52 |
| Interest Payable |
-- |
| Dividend Payable |
4,550,000.00 |
| Other payables |
72,199,453.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
82,140,893.08 |
| Other Current Liabilities |
2,667,868.98 |
| Sub-Total of Current Liabilities |
2,412,038,696.72 |
| Long-term Loans |
168,823,995.60 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
11,050,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,573,353.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
244,783,469.93 |
| Total Liabilities |
2,656,822,166.65 |
| Paid-In Capital(Or Share Stock) |
528,619,670.00 |
| Capital Surplus |
1,325,549,107.51 |
| Surplus Reserve |
77,633,968.69 |
| LESS:Treasury Stock |
21,453,648.28 |
| Undistributed Profits |
627,733,934.06 |
| Minority Stockholder's Interest |
45,146,334.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,538,915,547.07 |
| Owner's Equity（Stockholder's Equity） |
2,584,061,881.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,240,884,047.73 |
